Journal article
A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase
FEBS letters, Vol.410(2), pp.180-186
1997
DOI: 10.1016/S0014-5793(97)00574-7
PMID: 9237625
Abstract
CFTR–NBF-2 expressed and purified in fusion with the maltose-binding protein was shown to catalyse the reaction ATP→ADP+P
i by three different assays, monitoring ATP turnover, formation of ADP and release of P
i (
K
m 86 μM, rate constant 0.37 min
−1). The reaction product ADP inhibits this ATPase activity. In a similar manner the hydrolysis of GTP to GDP and P
i was demonstrated (
K
m 40 μM, rate constant 0.29 min
−1). In the presence of AMP the ATPase reaction was superseded by the formation of two ADP from ATP and AMP. As typical for adenylate kinases a distinct AMP-binding site could be verified for CFTR–NBF-2 by the inability of TNP–ATP and AMP to compete for binding. All three enzymatic activities were inhibited by the symmetric double-substrate-mimicking inhibitor Ap
5A. As NBF-2 plays a central role in CFTR channel opening and closing the results reported here are fundamental in understanding mechanisms of CFTR channel activity regulation.
Details
- Title: Subtitle
- A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase
- Creators
- Christoph Randak - Kinderklinik, Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität München, Lindwurmstraße 4, D-80337 München, GermanyPeter Neth - Kinderklinik, Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität München, Lindwurmstraße 4, D-80337 München, GermanyEnnes A Auerswald - Abteilung für Klinische Chemie und Klinische Biochemie, Chirurgischen Klinik und Poliklinik, Klinikum Innenstadt, Ludwig-Maximilians-Universität München, München, GermanyChristoph Eckerskorn - Max-Planck-Institut für Biochemie, Martinsried, GermanyIrmgard Assfalg-Machleidt - Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie, Ludwig-Maximilians-Universität München, München, GermanyWerner Machleidt - Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie, Ludwig-Maximilians-Universität München, München, Germany
- Resource Type
- Journal article
- Publication Details
- FEBS letters, Vol.410(2), pp.180-186
- Publisher
- Elsevier B.V
- DOI
- 10.1016/S0014-5793(97)00574-7
- PMID
- 9237625
- ISSN
- 0014-5793
- eISSN
- 1873-3468
- Language
- English
- Date published
- 1997
- Academic Unit
- Pulmonary Medicine; Stead Family Department of Pediatrics
- Record Identifier
- 9984093595802771
Metrics
16 Record Views